top of page

News & History

2023-11

SIVA being used as the first AI-based continuous ambulatory cough measurement system in a global drug development study, providing cough profiles over several weeks

2023-11

Completion of the European Union Medical Device Regulation (MDR) final audit. This will lead to the MDR certificate and CE marking, confirming SIVA Healths' compliance with the highest required regulatory standards.

2023-09

Participation at European Respiratory Society Congress 2023
in Milan

2023-07

SIVA Health AG becoming a fully independent company, owning all the IP generated.

2023-06

Participation at the American Cough Conference 2023 in Washington DC

2022-10

Clinical results of the SIVA validation study published in
ERJ Open Research
First publication on AI-based continuous ambulatory cough monitoring over several weeks with a large number of patients.

2022-09

Poster Presentation at European Respiratory Society Congress 2022 in Barcelona

2022-04

Certification according to EN ISO 13485:2016

2022-03

Poster Presentation at the Swiss Society of Pneumology Congress 2022 in Lucerne

2021-04

Start of clinical validation study at the University Hospital Zurich
First study on continuous cough monitoring over several weeks with a large number of patients

2020-04

Initiation of AI-based continuous ambulatory cough monitoring project in close collaboration with Bayer Pharmaceuticals

bottom of page